Standard BioTools Releases Financial Performance for Q3 2025
November 4, 2025 - 20:32
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 -- Standard BioTools Inc. has announced its financial results for the third quarter ending September 30, 2025. The company reported a total combined revenue of $46.2 million for the quarter, with revenue from continuing operations reaching $19.6 million.
In a strategic move to enhance operational efficiency, Standard BioTools has implemented a comprehensive restructuring plan aimed at generating over $40 million in annualized cost savings. This initiative is part of the company's broader strategy to streamline operations and improve financial performance.
Furthermore, the company is on track to achieve its target of positive adjusted EBITDA, reflecting its commitment to financial health and sustainability. These results underscore Standard BioTools' efforts to navigate the evolving market landscape and position itself for future growth. The company remains focused on delivering value to its stakeholders while adapting to the challenges and opportunities within the biotechnology sector.
MORE NEWS
July 6, 2026 - 17:52
COVID Tax Returns: Are you eligible to get them and what is the deadline to apply for them?Millions of Americans may still be owed money from COVID-era tax credits, but claiming those funds requires action before a looming deadline. The Internal Revenue Service has been notifying...
July 5, 2026 - 17:25
Campaign finance ruling could tighten ties between donors, parties and candidatesMADISON, Wis. - The U.S. Supreme Court this week removed federal limits on how much money national political party committees can spend in direct coordination with their candidates, a decision that...
July 5, 2026 - 00:20
1 Unstoppable Stock to Buy Before It Joins Google, Apple, Microsoft, and Nvidia in the $3 Trillion ClubTaiwan Semiconductor Manufacturing Company, better known as TSMC, is quietly positioning itself to join the most exclusive club in the stock market. Right now, only four companies have reached a...
July 4, 2026 - 02:50
Is Inter & Co, Inc. (INTR) A Good Stock To Buy Now?A bullish thesis on Inter & Co, Inc. recently appeared on the Emerging Value Substack, drawing attention to the stock`s potential. As of June 29th, shares of INTR were trading at $5.38, with a...